UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 7, 2006
ALEXANDRIA REAL ESTATE EQUITIES, INC.
|
|
|
|
|
|
385 East Colorado Boulevard, Suite 299
Pasadena, California 91101
(626) 578-0777
N/A
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 8.01 Other Events
On June 7, 2006, Alexandria Real Estate Equities, Inc. (the "Company") announced it had executed a 12-year lease with Genentech, Inc. for a ground-up development of an approximately 121,000 square foot four-story facility in South San Francisco, California. The Company also announced it signed its first lease at Alexandria's Center for Translational Research at Mission Bay.
The press release issued on June 7, 2006 is attached hereto as Exhibit 99.1 and is filed herewith.
ITEM 9.01 Financial Statements and Exhibits
(d) Exhibits
99.1 Press Release dated June 7, 2006.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
ALEXANDRIA REAL ESTATE EQUITIES, INC. |
June 9, 2006 |
By: /s/ DEAN A. SHIGENAGA |
Dean A. Shigenaga |
|
Chief Financial Officer |
EXHIBIT INDEX
|
Exhibit Title |
|
* Also provided in PDF format as a courtesy.